scholarly journals Sequence-specific RNA cleavage by PNA conjugates of the metal-free artificial ribonuclease tris(2-aminobenzimidazole)

2015 ◽  
Vol 11 ◽  
pp. 493-498 ◽  
Author(s):  
Friederike Danneberg ◽  
Alice Ghidini ◽  
Plamena Dogandzhiyski ◽  
Elisabeth Kalden ◽  
Roger Strömberg ◽  
...  

Tris(2-aminobenzimidazole) conjugates with antisense oligonucleotides are effective site-specific RNA cleavers. Their mechanism of action is independent of metal ions. Here we investigate conjugates with peptide nucleic acids (PNA). RNA degradation occurs with similar rates and substrate specificities as in experiments with DNA conjugates we performed earlier. Although aggregation phenomena are observed in some cases, proper substrate recognition is not compromised. While our previous synthesis of 2-aminobenzimidazoles required an HgO induced cyclization step, a mercury free variant is described herein.

RSC Advances ◽  
2016 ◽  
Vol 6 (96) ◽  
pp. 93398-93402 ◽  
Author(s):  
Xingyu Wang ◽  
Xingguo Liang

Photoresponsive azobenzene-modified antisense oligonucleotides for site-specific RNA cleavage by RNase H.


2017 ◽  
Vol 25 (9) ◽  
pp. 2075-2092 ◽  
Author(s):  
Xue-Hai Liang ◽  
Hong Sun ◽  
Joshua G. Nichols ◽  
Stanley T. Crooke

1996 ◽  
Vol 24 (4) ◽  
pp. 760-765 ◽  
Author(s):  
M. A. Reynolds ◽  
T. A. Beck ◽  
P. B. Say ◽  
D. A. Schwartz ◽  
B. P. Dwyer ◽  
...  

2018 ◽  
Vol 42 (20) ◽  
pp. 17021-17032 ◽  
Author(s):  
Sivaraj Mehnath ◽  
Mukherjee Arjama ◽  
Mariappan Rajan ◽  
Murugaraj Jeyaraj

The aim of the present study was to explore the tumor targeting potential of a cholic acid (CA) conjugated polymeric micelle system for the effective delivery of paclitaxel (PTX).


2020 ◽  
Vol 152 ◽  
pp. 1027-1037 ◽  
Author(s):  
Priyanka Kaushik ◽  
Eepsita Priyadarshini ◽  
Kamla Rawat ◽  
Paulraj Rajamani ◽  
H.B. Bohidar

2020 ◽  
Vol 48 (4) ◽  
pp. 1691-1700 ◽  
Author(s):  
Michael E Østergaard ◽  
Cheryl L De Hoyos ◽  
W Brad Wan ◽  
Wen Shen ◽  
Audrey Low ◽  
...  

Abstract Therapeutic oligonucleotides are often modified using the phosphorothioate (PS) backbone modification which enhances stability from nuclease mediated degradation. However, substituting oxygen in the phosphodiester backbone with sulfur introduce chirality into the backbone such that a full PS 16-mer oligonucleotide is comprised of 215 distinct stereoisomers. As a result, the role of PS chirality on the performance of antisense oligonucleotides (ASOs) has been a subject of debate for over two decades. We carried out a systematic analysis to determine if controlling PS chirality in the DNA gap region can enhance the potency and safety of gapmer ASOs modified with high-affinity constrained Ethyl (cEt) nucleotides in the flanks. As part of this effort, we examined the effect of systematically controlling PS chirality on RNase H1 cleavage patterns, protein mislocalization phenotypes, activity and toxicity in cells and in mice. We found that while controlling PS chirality can dramatically modulate interactions with RNase H1 as evidenced by changes in RNA cleavage patterns, these were insufficient to improve the overall therapeutic profile. We also found that controlling PS chirality of only two PS linkages in the DNA gap was sufficient to modulate RNase H1 cleavage patterns and combining these designs with simple modifications such as 2′-OMe to the DNA gap resulted in dramatic improvements in therapeutic index. However, we were unable to demonstrate improved potency relative to the stereorandom parent ASO or improved safety over the 2′-OMe gap-modified stereorandom parent ASO. Overall, our work shows that while controlling PS chirality can modulate RNase H1 cleavage patterns, ASO sequence and design are the primary drivers which determine the pharmacological and toxicological properties of gapmer ASOs.


2000 ◽  
Vol 44 (1) ◽  
pp. 279-280 ◽  
Author(s):  
H. Inoue ◽  
T. Furukawa ◽  
T. Tamura ◽  
Y. Komatsu ◽  
E. Ohtsuka
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document